ICHD-II Diagnostic Criteria for Migraine. Migraine without aura
|
|
- Ashlynn Murphy
- 7 years ago
- Views:
Transcription
1 ICHD-II Diagnostic Criteria for Migraine Migraine without aura A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) C. Headache has at least 2 of the following characteristics: Unilateral location Pulsating quality Moderate or severe pain intensity Aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs) D. During headache at least 1 of the following: Nausea and/or vomiting Photophobia and phonophobia E. Not attributed to another disorder Migraine with aura A. At least 2 attacks fulfilling criterion B B. Migraine aura fulfilling criteria B-C for one of the subforms (typical aura with migraine headache, typical aura with non-migraine headache, typical aura without headache, familial hemiplegic migraine, sporadic hemiplegic migraine, or basilar-type migraine) C. Not attributed to another disorder
2 Level A = >2 Class I studies Level B = 2 Class II studies Level C = 1 Class II study Level U = Inadequate data Class I: RTC Class II: Cohort Class III: other controlled studies. Class IV: uncontrolled studies
3 Drug name (in alphabetical order) Acetaminophen Beta Blockers Dosage information Side effects Misc. -Some patients find 500mg or 1000mg effective -Propranolol: starting dose is usually 20mg and usual effective dose mg -Timolol: starting dose is usually 10mg and usual effective dose is 20-30mg -Nadolol: starting dose is 40mg and usual effective dose is 40-80mg -Metoprolol: effective dose is usually 200mg/day -Hepatotoxicity at doses over 4g/day in average adults. Caution in patients with liver disease -Side effects include fatigue, sedation, weight gain, orthostatic hypotension -Contraindicated in patients (1) with diabetes since it may mask the response to hypoglycemia (2) asthmatic patients (3) depressed patients Typically if one beta blocker fails, better results are not often obtained with other beta blockers Butter Burr (also known as Petasite hybridus plant extract, marked as under the brand name Petadolex) Butorphanol (opiate agonist-antagonist) Calcium Channel Blockers Dihydroergotamine (serotonin, dopamine, catecholamine receptor agonist) -50mg to 75mg BID -Available as a nasal spray. Usual dosage is 2mg to 4mg -When effective, the usual dose of verapamil is between 80 and 240mg /day -Most commonly administered IV form as part of the Raskin protocol but also has nasal spray and subcutaneous formulations. -Chemically unstable when exposed to air or light and must be kept -Safety of prolonged use is not established. Can cause upset stomach predominantly burping. Can have liver toxicity -Can cause dysphoria, hallucinations, and sedation -A small group of patients may respond well to calcium channel blockers and these patients often have tacyphylaxis after 2 or 3 months and need a period of at least 1 month off the medication to restore responsiveness -Metabolites accumulate with repeated dosing and can cause irritability, sedation, peripheral edema, and vasoconstriction
4 Ergotamine (5HT-1-B and 1-D agonists) refrigerated in the dark -1mg at onset of headache, 1 mg at 30minutes if needed, 1mg/hr up to 6mg/day. Maximum 6mg/d or 10mg/wk -Also available as a suppository -Much lower incidence of peripheral and coronary vasospasm than ergotamine -Can cause coronary vasoconstriction. -Long term use can cause peripheral cyanosis, acroparethesia, and peripheral neuropathy. These effects may be because of microvascular constriction of separate neurotoxic effects of ergotamine -Frequent use may trigger rebound headaches Feverfew -100mg daily -may cause GI upset and irritation of mouth and tongue Gabapentin Isometheptene combinations (most common brand formation is Midrin; combination of isomethephen mucate, dichloralphenazone and acetaminophen) -Start at 100mg to 300mg/day. Increase every 3 to 7 days to 900mg to 1800mg/day. The effective dose is usually between 600mg/day and 2,400mg/day -Up to six capsules per day -Side effects are sedation, irritability, depression and difficulty thinking -Side effects are drowsiness, bad taste and elevated blood pressure Magnesium -300mg daily -Side effects are cramping, diarrhea N-alpha-methylhistamine -1-10ng 2 times/week SC -Transient itching at the injection site NSAIDs -At times, larger doses such as 1000mg aspirin, 800mg ibuprofen, 500mg naproxen may be necessary -Can cause GI irritation. Riboflavin (Vitamin B2) -400mg daily Topiramate -Start at 25mg/day and increase by -May cause somnolence, -effect thought to be mediated by prostaglandin inhibition.
5 Tricyclic antidepressants Triptans (serotonin agonists) 25mg/day. Most patients respond between 25mg and 200mg/day -Can dose one third in the morning and two thirds at night. Some patients prefer to receive entire dose at night -Amitriptyline s starting dose is 10 to 25mg and is increased every 1 to 2 weeks by 10 mg to 25mg with maximum dose 300mg/day -At doses greater than 200mg/day, the tricyclic blood level should be measured and if it is greater than 300mg/mL the dose should be decreased -The dose should be divided in two or three times a day with the largest dose at bedtime -Dosage can be repeated in 2 hours. -Max daily doses: Sumatriptan PO (200mg), nasal (40mg) and SC (12mg), Zolmitriptan PO (10mg) and nasal (10mg), Rizatriptan PO (20mg), Naratriptan PO (10mg), Eletriptan PO (160mg), Almotriptan PO (25mg), Frovatriptan PO (5mg) --Frovatriptan can be particularly useful for menstrual migraines 2.5mg bid. Two days prior to expected onset of menstrual migraines can take 2.5mg bid, then on second treatment day can take 2.5mg daily for five limb paraesthesias, word finding difficulty, metallic taste -May have weight loss of up to 5-7% of body mass. -May precipitate kidney stone formation -May trigger acute glaucoma -Has an increased risk of cleft palate in the fetus -anticholingeric effects (Dry mouth, constipation, difficult/slow urination) -2%-5% will have paradoxical anxiety and stimulation -may lower seizure threshold and should not be given to patient with seizure history who is not on AEDs -Can cause arrhythmias so in patients 50 years or older or patients with cardiac disease ECG is recommended before administration -contraindicated in patients with ischemic heart disease or ischemic cerebrovascular syndromes -can cause dizziness, fatigue, flushing -Favored in patients with chronic daily headaches -Sometimes is combined with propranolol. Some patient experience an additive effect -For oral administration response onset is within 30 to 60 minutes and peaks at about 2 hours -Sumatriptan subcutaneous has the fastest onset of relief in 10 to 20 minutes -Rizatriptan and zolmitriptan have rapidly melting tablets. -Sumatriptan and zolmitriptan nasal sprays can be used when the patient is too nauseated to take the tablet. Zolmitriptan nasal spray is faster onset than the tablet
6 Valproic Acid Venlafexine (Effexor) consecutive days. If only mildly effective, this regimen can be doubled to 5mg bid x 1 day, then 5mg daily x 5 days -Start at 250mg daily or bid and increase by 250mg/day each week to a maximum of 500mg tid. -Doses higher than 1,500mg/d usually do not provide further improvement in headache -Start at 37.5mg or 75mg and can increase by at most 75mg every 4 day -doses of 150mg ER daily shown to be effective -Caution in women: there is an increased risk of neural tube closure defects (1%) and polycystic ovarian syndrome -Potential of hepatoxicity because of effect on carnitine metabolism. Risk is higher in children -headache, somnolence, dizziness -Response to the triptans tend to be idiosyncratic therefore individual patients may respond well to one triptan and less well to another References: Jose Biller, Practical Neurology (Philadelphia: Lippincott, Williams, and Wilkins, 2009), Stephen Silberstein et al., Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; Stephen Silberstein et al., Evidence-based guideline update: Pharmacological treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78: Stephen Silberstein et al., Evidence-based guideline update: NSAIDS and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78:
Sporadic attacks of severe tension-type headaches may respond to analgesics.
MEDICATIONS While we are big advocates of non-drug treatments, many people do require the use of medications to control headaches. Headache medications are divided into two categories. Abortive drugs are
More information8/23/2015 A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH A PRACTICAL OPTOMETRIC HEADACHE APPROACH
8/23/2015 A Practical Optometric Approach To Headaches Leonid Skorin, Jr., OD, DO, MS, FAAO, FAOCO Consultant, Department of Surgery Community Division of Ophthalmology Mayo Clinic Health System in Albert
More informationPatient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg
Patient Information ONZETRA TM (On ze' trah) Xsail TM (Eks'-seil) (sumatriptan nasal powder) 11 mg Read this Patient Information before you start using ONZETRA Xsail and each time you get a refill. There
More informationNone related to the presentation Grants to conduct clinical trials from:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationMigraine The Problem: Common Symptoms:
Migraine The Problem: A combination of genetic and environmental factors alter pain mechanisms in your brain Transient changes in brain chemicals such as serotonin and neuropeptides affect the membranes
More informationPost-Concussive Headaches and Dizziness Louise M. Klebanoff, MD
Post-Concussive Headaches and Dizziness Louise M. Klebanoff, MD Associate Professor and Vice Chairman for Operations Chief, General Neurology Department of Neurology Disclosures: None Introduction: Headaches
More informationEvaluation of Headache Syndromes and Migraine
Evaluation of Headache Syndromes and Migraine Sonja Potrebic MD PhD Department of Neurology Los Angeles Kaiser Objectives 1) Identify the diagnostic features of migraine Differentiate from sinusitis 2)
More informationPost Traumatic and other Headache Syndromes. Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA
Post Traumatic and other Headache Syndromes Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA Over 45 million Americans have chronic, recurring headaches 62% of these
More informationMIGRAINE: QUESTIONS AND ANSWERS FOR PATIENTS Headache Research and Treatment Program Department of Neurology, David Geffen School of Medicine at UCLA
MIGRAINE: QUESTIONS AND ANSWERS FOR PATIENTS Headache Research and Treatment Program Department of Neurology, David Geffen School of Medicine at UCLA What is a migraine? Migraine is not just a headache,
More informationMIGRAINE. Denise Cambier M.D. Delaware Neurology, Ohio Health March 2013
MIGRAINE Denise Cambier M.D. Delaware Neurology, Ohio Health March 2013 HISTORY: Graham and Wolff 1938: decreased amplitude of arterial pulsations coincided with reduction of headache with IV ergotamine.
More informationKids get headaches too! Evaluation and treatment of the pediatric headache
3:45 4:25pm Approach to the Child with Headaches SPEAKER Jason T. Lerner, MD Presenter Disclosure Information The following relationships exist related to this presentation: Jason T. Lerner, MD: No financial
More information11/18/2015. Neurology Update Migraine Headaches. Disclosure Statement. Objectives. Diagnosis of Migraine. Acute Migraine Treatment
Disclosure Statement Neurology Update Migraine Headaches Ralph T. Dunnigan, M.D. Mid Dakota Clinic Bismarck ND DISCLOSURE OF CONFLICT OF INTEREST A commercial interest is any entity producing, marketing,
More informationHeadaches in Children How to Manage Difficult Headaches
Headaches in Children How to Manage Difficult Headaches Peter Procopis Childhood headaches Differential diagnosis Migraine Psychological Raised Pressure Childhood headaches Other causes: Constitutional
More informationWhat is chronic daily headache? Information for patients Neurology
What is chronic daily headache? Information for patients Neurology What is chronic daily headache (CDH)? Chronic daily headache (CDH) is the term used when a person has a headache on 15 days a month or
More informationEmergency and inpatient treatment of migraine: An American Headache Society
Emergency and inpatient treatment of migraine: An American Headache Society survey. The objective of this study was to determine the practice preferences of AHS members for acute migraine treatment in
More informationSumatriptan (Imitrex ) Utilization Management Criteria
Sumatriptan (Imitrex ) Utilization Management Criteria DRUG CLASS: BRAND (generic) NAME: 5HT1 agonists Imitrex (sumatriptan) Sumavel DosePro (sumatriptan) Injection kit or refill (GCN = 050741) Injection
More informationThe Pediatric Headache Handbook
The Pediatric Headache Handbook For the Primary Care Physician Brought to you by the Division of Child Neurology Classification of headache patterns in children Acute onset of worst headache of my life
More information4.1 How can migraine treatments be assessed and rated? 86 STRATEGIES FOR USING MIGRAINE THERAPIES
Migraine treatments 4 4.1 How can migraine treatments be assessed and rated? 86 STRATEGIES FOR USING MIGRAINE THERAPIES 4.2 What are the strategies for treating migraine? 86 4.3 How should behavioural
More informationSUMATRIPTAN (IMITREX ) UTILIZATION MANAGEMENT CRITERIA
SUMATRIPTAN (IMITREX ) UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: 5HT1 agonists BRAND NAME: Imitrex 4 mg injection kit or refill (Generic) (sumatriptan) 6 mg injection kit or refill Injection vial (1
More informationHEADACHE. as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D.
HEADACHE as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D. Dpt. of Neurology Charles University in Prague, 2nd Faculty of Medicine Motol University Hospital History of headache 1200 years B.C.
More informationMedications for chronic pain
Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may
More informationPediatric Migraine Management
Pediatric Migraine Management STEVEN M. WOLF, MD Director of Pediatric Epilepsy Beth Israel Medical Center New York, N.Y. PATTY MCGOLDRICK, CPNP Pediatric Neurology Beth Israel Medical Center New York,
More informationMigraine Treatment - What You Should Know
What kind of headache do you have? Less than 2% of the population have never had a headache. Most of us get them from time to time and they are usually resolved with a couple of painkillers, a rest or
More informationEvidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks
Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks David B. Matchar, MD Professor of Medicine and Director, Center for Clinical Health
More informationMigraines. Brought to you by the Waynesburg University Student Health Services
Migraines Brought to you by the Waynesburg University Student Health Services For God is not unjust; He will not forget your work and the love you showed for His name when you served the saints and you
More informationKids Get Headaches Too
health information Kids Get Headaches Too Alberta Health Services It is hard to see your child in pain. It can be frustrating or scary for a child to have headaches. In this booklet you will learn about:
More informationAcute Treatment of Migraine
Acute Treatment of Migraine Headache Cooperative of New England (HCNE) Topnotch at Stowe, VT March 6, 2009 ALAN M. RAPOPORT, M.D. Founder and Director-Emeritus The New England Center for Headache Stamford,
More informationPlease fill out (in medium blue or black pen) as completely as possible and bring to your first visit.
PATIENT S NAME MED. REC. # PATIENT QUESTIONNAIRE HEADACHE DOB Patient Identification Please fill out (in medium blue or black pen) as completely as possible and bring to your first visit. Patient Name:
More informationAcute treatment of migraine headache
Techniques in Regional Anesthesia and Pain Management (2009) 13, 9-15 Acute treatment of migraine headache Marisa Chang, MD, a Alan M. Rapoport, MD a,b From the a Department of Neurology, The David Geffen
More informationZomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION
Zomig Nasal Spray Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about It does not contain all
More informationAcute & Prophylactic Treatments for Migraine Headache
Acute & Prophylactic Treatments for Migraine Headache Release Date: 03/08/2012 Expiration Date: 03/08/2015 FACULTY: Lenore Howe, BS, MS FACULTY AND ACCREDITOR DISCLOSURE STATEMENTS: Ms. Howe has no actual
More informationUNIT VIII NARCOTIC ANALGESIA
UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and
More informationCare Manager Resources: Common Questions & Answers about Treatments for Depression
Care Manager Resources: Common Questions & Answers about Treatments for Depression Questions about Medications 1. How do antidepressants work? Antidepressants help restore the correct balance of certain
More informationTreatment Options for Acute Migraine
Treatment Options for Acute Migraine a report by Andrew J Dowson Director of the King s Headache Service, King s College Hospital DOI:10.17925/ENR.2006.00.02.28 Introduction Migraine Treatments Andrew
More informationMigraine Madness: Treatment of Childhood Migraine. Candida M. Brown, MD. Division of Neurology
Migraine Madness: Treatment of Childhood Migraine Candida M. Brown, MD Division of Neurology Following print-publication of The International Classification of Headache Disorders, 2 nd edition (ICHD-II),
More informationSIGN. Diagnosis and management of headache in adults. Quick Reference Guide. Scottish Intercollegiate Guidelines Network
SIGN Scottish Intercollegiate Guidelines Network 107 iagnosis and management of headache in adults Quick Reference Guide November 2008 opies of all SIGN guidelines are available online at www.sign.ac.uk
More informationButalbital/caffeine with ASA 1-2 tabs P.O. at onset. May repeat 1 tab Contraindicated in porphyria
Page 1 of 7 Headache Medication Table Recommended Dosages Medication for Adults Comments Acetylsalicylic acid (aspirin, 650 to 1,000 mg every 4 to 6 hours. Metoclopramide [F] ( only) 10 mg P.O. ASA) [OTC]
More informationProper Diagnosis and Treatment for the Headache Patient Alexander Feoktistov MD, PhD
Proper Diagnosis and Treatment for the Headache Patient Alexander Feoktistov MD, PhD Director of Clinical Research Diamond Headache Clinic Chicago, IL 2014 Objectives Get familiar with primary headache
More informationDiagnosis and Management of Migraine Headaches
Diagnosis and Management of Migraine Headaches Elizabeth C. Lawrence, MD Abstract: Migraine headaches afflict approximately 6% of men and 18% of women in the United States, and cost billions of dollars
More informationAcute and Preventive Treatment of Migraine Paul B. Rizzoli, MD, FAAN
Review Article Address correspondence to Dr Paul B. Rizzoli, BW/Faulkner Neurology, John R. Graham Headache Center, 1153 Centre St, Suite 4970, Jamaica Plain, MA 02130, prizzoli@partners.org. Relationship
More informationAdult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention
Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network
More informationChronic Headaches. David R. Greeley, MD, FAAN Northwest Neurological, PLLC October 23, 2015
s David R. Greeley, MD, FAAN Northwest Neurological, PLLC October 23, 2015 Why is Headache Important? 36,000,000 people have migraine - more than asthma and diabetes combined 13,000,000 have chronic daily
More informationPlease be sure to list all therapies that have been previously tried on the request form so that your request can be processed in a timely manner.
Drug Therapy Guidelines: Migraine Agents Axert (almotriptan), Relpax (eletriptan), Frova (frovatriptan), Amerge (naratriptan), Maxalt/MLT (rizatriptan), Imitrex (sumatriptan), Zomig/ZMT (zolmitriptan),
More informationUltram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.35 Subject: Tramadol Acetaminophen Page: 1 of 8 Last Review Date: September 18, 2015 Tramadol Acetaminophen
More informationContents Page. 1. What is IV DHE? 3. 2. Medication Licence 3. 3. How can a course of IV DHE help? 4. 4. What are the side effects of IV DHE?
If you would like this document in another language or format, or if you require the services of an interpreter, please contact us on extension 84299 or 83926. Switchboard: 0845 155 5000 020 3456 7890
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationAmitriptyline. Drug information Amitriptyline
Drug information Amitriptyline Amitriptyline This leaflet provides information on amitriptyline and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets
More informationTrileptal (Oxcarbazepine)
Brand and Generic Names: Trileptal Tablets: 150mg, 300mg, 600mg Liquid Suspension: 300mg/5mL Generic name: oxcarbazepine What is Trileptal and what does it treat? Trileptal (Oxcarbazepine) Oxcarbazepine
More informationControlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer
Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.
More informationMigraine headaches are a
PRACTICAL THERAPEUTICS Management of the Acute Migraine Headache GLEN AUKERMAN, M.D., DOUG KNUTSON, M.D., and WILLIAM F. MISER, M.D., M.A. Ohio State University College of Medicine and Public Health, Columbus,
More informationPOST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
More informationRecognition and management of common headaches encountered in Primary Care. By Alan Gindoff DHSc, PA-C
Recognition and management of common headaches encountered in Primary Care By Alan Gindoff DHSc, PA-C Disclosure Statement Dr. Gindoff has no relevant financial or non financial relationships to disclose.
More informationAmerican Headache Society Evidence Assessment
Headache 2015 American Headache Society ISSN 0017-8748 doi: 10.1111/head.12499 Published by Wiley Periodicals, Inc. American Headache Society Evidence Assessment The Acute Treatment of Migraine in Adults:
More informationMigraine Treatment in Women: Treat Options and Referral
Migraine Treatment in Women: Treat Options and Referral Frederick G. Freitag, D.O., F.A.H.S Director of Headache Medicine Program Associate Professor Department of Neurology Medical College of Wisconsin
More informationHeadache Help for Your Child or Teen
Patient and Family Education Headache Help for Your Child or Teen Headaches are a common problem for kids and teens. This flyer will help you to understand some of the ways you can help your child or teen
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationHeadache Classification. Headache Classification 6/4/2014. Primary Care Approach to Chronic Headache
Primary Care Approach to Chronic Headache Headache Classification Primary Headaches Tension Migraine Cluster (Trigeminal Autonomic Cephalalgias) Other Primary Headache Classification Secondary Headaches
More informationCases in Neurology. Migraine is the most common cause of recurrent. What to do About the Child with Headaches. Case 1: Mary s pain
What to do About the Child with Headaches Sheikh Nigel Basheer, MB; and Kevin Farrell, MB Presented at UBC s 11th Annual Pediatric and Adolescent Refresher for General Practitioners, 2003 Migraine is the
More informationHeadaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
More informationClinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More informationUsing the Triptans to Treat: Migraine Headaches. Comparing Effectiveness, Safety, and Price
Using the Triptans to Treat: Migraine Headaches Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................
More informationACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationDRUG INTERACTIONS: WHAT YOU SHOULD KNOW. Council on Family Health
DRUG INTERACTIONS: WHAT YOU SHOULD KNOW Council on Family Health Drug Interactions There are more opportunities today than ever before to learn about your health and to take better care of yourself. It
More informationTreatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:
Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through
More informationMigraine Agents Quantity Limit Program Summary
Migraine Agents Quantity Limit Program Summary Program applies to GenRx Open, GenRx Closed, Health Insurance Marketplace, FlexRx Open, FlexRx Closed and Medicaid. For the GenRx Closed Formulary, nonpreferred
More informationBasic Medications Activity 1
Basic Medications Activity 1 Directions: Choose the correct meaning for each abbreviation listed below and write it in the blank. Abbreviation Meaning q.i.d (QID) afternoon/evening morning Tab teaspoon
More informationHeadaches in Children
Children s s Hospital Headaches in Children Manikum Moodley, MD, FRCP Section of Pediatric Neurology The Cleveland Clinic Foundation Introduction Headaches are common in children Most headaches are benign
More informationWhat You Should Know
What You Should Know Will this medicine work for me? The antidepressants presented in this decision aid all work the same for treating depression. Most people with depression can find one that can make
More informationPaxil/Paxil-CR (paroxetine)
Generic name: Paroxetine Available strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 10 mg/5 ml oral suspension; 12.5 mg, 25 mg, 37.5 mg controlled-release tablets (Paxil-CR) Available in generic: Yes, except
More informationHeadaches in Primary Care: An Approach to Management 2015 Update
Headaches in Primary Care: An Approach to Management 2015 Update Kathleen B. Digre MD Professor Neurology, Ophthalmology Adjunct Professor Anesthesia, Obstetrics and Gynecology UNIVERSITY OF UTAH Disclosures:
More informationANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
More informationWhy are antidepressants used to treat IBS? Some medicines can have more than one action (benefit) in treating medical problems.
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD What are functional GI disorders? There are more
More informationUpstate University Health System Medication Exam - Version A
Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication
More informationOne Day at a Time: When Headaches Become Chronic. Robert Shapiro, MD, PhD
One Day at a Time: When Headaches Become Chronic Robert Shapiro, MD, PhD Disclosures Scientific/Medical Advisory Boards (since 10/12) Transcept Pharmaceuticals Chronic Headaches: Overview What is a chronic
More informationGuidance for Industry Migraine: Developing Drugs for Acute Treatment
Guidance for Industry Migraine: Developing Drugs for Acute Treatment DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationLevels of evidence and grades of recommendation
MOH Clinical Practice Guidelines 5/2007 Levels of evidence and grades of recommendation Levels of evidence Level Type of Evidence 1 + + High quality meta-analyses, systematic reviews of randomised controlled
More informationWHAT IS MIGRAINE? Aura without Headache About 1% of migraineurs experience the aura symptoms of migraine without ever having a headache.
WHAT IS MIGRAINE? Migraine is the most common neurological condition in the world, affecting about 1 in 10 people. It is 3 times more common in women and is usually inherited. It is a very individual condition.
More informationSystematic Review of Treatment for Alcohol Dependence
Systematic Review of Treatment for Alcohol Dependence ALCOHOL ARCUATE NUCLEUS in Hypothalamus, pituitary Beta-endorphin Dynorphin Kappa receptor Nucleus Enkephalins accumbens Delta receptor (+) Mu receptor
More informationAdrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers
Adrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers Objective 1: Explain the difference between the sympathetic and parasympathetic nervous systems Autonomic Nervous System Sympathetic
More informationMEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets
MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets Savella is not used to treat depression, but it acts like medicines that are used to treat depression (antidepressants) and other psychiatric
More informationDo Your Patients Have Migraines That Are Long in Duration and/or Recur?
Do Your Patients Have s That Are Long in Duration and/or Recur? attacks Can Be FROVA and often Was recur Generally 1-4 Well Characteristics associated with migraines that are long in duration and/or recur
More informationKaren Drexler, M.D. ALCOHOLISM AND DEPRESSION
Karen Drexler, M.D. for the DUMC Alcohol Awareness Task Force ALCOHOLISM AND DEPRESSION Overview What is major depression? What is alcohol dependence? Does depression lead to alcohol dependence? Does alcohol
More informationINITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
More informationTreating Severe Migraine Headaches in the Emergency Room A Review of the Research for Adults
Treating Severe Migraine Headaches in the Emergency Room A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that
More informationNovartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
More informationAdvances in Migraine Management: Implications for Managed Care Organizations
In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm. Advances in Migraine Management: Implications for Managed Care Organizations
More informationFEDERAL BUREAU OF PRISONS CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HEADACHE September 2003
FEDERAL BUREAU OF PRISONS CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HEADACHE September 2003 PURPOSE The Federal Bureau of Prisons Clinical Practice Guidelines for the Management of Headache provide
More informationClinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD 20850 www.mamsi.com
Clinical Practice Guideline: Depression in 4 Taft Court Rockville, MD 20850 www.mamsi.com 40 05 17 035 3/03 Once a primary care patient presents with depressive symptoms, the primary care physician makes
More informationSR 5. W2364A_NT.XATRAL SR5 PAK/SA 5/12/05 9:47 Page 1
W2364A_NT.XATRAL SR5 PAK/SA 5/12/05 9:47 Page 1 alfuzosin SR 5 mg (Alfuzosin HCI) COMPOSITION Each sustained-release, film-coated tablet contains: Alfuzosin hydrochloride......... 5 mg Excipients... q.s.
More informationNursing 113. Pharmacology Principles
Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics
More informationutahneurosciences.com
Headache A Patient s Guide Clinical Neurosciences Center 729 Arapeen Drive Salt Lake City, Utah 84108 801.585.7575 utahneurosciences.com Headache: A Patient s Guide Headache is an extremely common problem.
More informationCBT/OTEP 243 Aspirin Administration for ACS
Seattle-King County EMS Seattle-King County Emergency Medical Services Division Public Health - Seattle/King County 401 5th Avenue, Suite 1200 Seattle, WA 98104 (206) 296-4693 February 2009 CBT/OTEP 243
More informationWhen the Pain Won t Stop: Managing Chronic Daily Headache
When the Pain Won t Stop: Managing Chronic Daily Headache Arnolda Eloff, MB, ChB, Mmed Presented at the University of Calgary s Wednesday Evening Course Program, Calgary, Alberta. Copyright Chronic daily
More informationWhat You Should Know
What You Should Know Will this medicine work for me? The antidepressants presented in this decision aid all work the same for treating depression. Most people with depression can find one that can make
More informationUsual total daily dosage *Indicates usual starting dose in mg/kg/day (mg of AED per kg of the child s weight per day) Drug (Generic Name)
Table of Anti Epileptic Drugs (AEDs) used in the treatment of Epilepsy in Children under 12. IMPORTANT All the tables below are guidelines only, giving average daily dose ranges. Treatment will generally
More informationNaltrexone: (Vivitrol )
Naltrexone: Injectable Formulation (Vivitrol ) 1 Opioid Receptors and Alcohol Dependence 4 1. Gianoulakis C. Alcohol Health Res World. 1998;22:202-210. 2. Woodward JJ. Principles of Addiction Medicine.
More informationDepakote (divalproex sodium) - Valproic Acid
Depakote (divalproex sodium) - Valproic Acid Brand and Generic Names Depakene (Valproic acid) Immediate release Syrup: 250 mg/5ml (there is 250 mg in one teaspoonful) Capsules: 250 mg Depakote /Depakote
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationPHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
More information